Key result
Apolipoprotein J overexpression attenuates cholesterol crystal-induced macrophage inflammation by inhibiting the NLRP3 inflammasome.
Why the study?
Apolipoprotein J may play a protective role in cardiovascular disease, but the exact mechanisms remain unclear.
Does over-expression of apolipoprotein J reduce cholesterol crystal-induced inflammation in THP-1 macrophages?
Does over-expression of apolipoprotein J reduce cholesterol crystal-induced inflammation in THP-1 macrophages?
p-value: p=<0.05
Over-expression of apolipoprotein J attenuates cholesterol crystal-induced inflammation in macrophages by inhibiting the NLRP3 inflammasome pathway, providing a mechanistic basis for its protective role in cardiovascular disease.
Preclinical macrophage data should not change practice; leaves open apolipoprotein J as a therapeutic target in atherosclerosis.
Apolipoprotein J (clusterin) is a component of high-density lipoproteins, the high level of which is reversely correlated with the risk of coronary heart disease. In addition, it exerts anti-inflammatory and anti-apoptotic effects on endothelial cells and inhibits smooth muscle cell migration and proliferation, indicating that it may play a protective role in cardiovascular disease. However, the exact mechanisms by which this occurs remain unclear. This study aimed to clarify these underlying protective mechanisms by researching the inhibitory effects of apolipoprotein J via the NOD-like receptor protein 3 pathway on the inflammation induced by cholesterol crystals in THP‑1 macrophages. In culture, THP-1 macrophages were infected with adenoviral vectors containing apolipoprotein J genes and subsequently treated with cholesterol crystals. The inflammatory cytokines interleukin‑1β, interleukin 18 and tumour necrosis factor α were quantitatively measured with ELISA kits. NOD-like receptor protein 3, cysteinyl aspartate specific proteinase 1 and interleukin 1β were evaluated by Western blot and PCR analysis. As a result, apolipoprotein J expression was found to remarkably decrease the levels of inflammatory cytokines, including tumour necrosis factor α, interleukin 18 and interleukin 1β, secreted by THP‑1 macrophages. It was also found capable of inhibiting the levels of NOD-like receptor protein 3, cysteinyl aspartate-specific proteinase 1 and interleukin 1β both at the protein and mRNA levels. In the current study, we revealed that over-expression of apolipoprotein J attenuated the inflammation induced by cholesterol crystals through inhibition of the NOD-like receptor protein 3 inflammasome pathway.
No takes yet. Share an insight, caveat, or question.
Li et al. (2021) studied Cholesterol crystal-induced inflammation (Atherosclerosis model). Apolipoprotein J (ApoJ) over-expression vs. pAD-IRES-EGFP adenoviral vector was evaluated on Expression of NLRP3, caspase-1, and secretion of IL-1β, IL-18, and TNF-α (p=<0.05). Over-expression of apolipoprotein J significantly attenuated cholesterol crystal-induced inflammation in THP-1 macrophages by inhibiting the NLRP3 inflammasome pathway.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: